Clinical Chemistry Siemens Point of Care - Urinalysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 52: 1193-1196, 2006. First published April 13, 2006; 10.1373/clinchem.2005.062505
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow 062505.Supplemental data
Right arrow All Versions of this Article:
clinchem.2005.062505v1
52/6/1193    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodríguez Cabaleiro, D.
Right arrow Articles by Thienpont, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodríguez Cabaleiro, D.
Right arrow Articles by Thienpont, L. M.
Related Collections
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2006;52:1193-1196.)
© 2006 American Association for Clinical Chemistry, Inc.

Technical Briefs

Feasibility of Standardization of Serum C-Peptide Immunoassays with Isotope-Dilution Liquid Chromatography–Tandem Mass Spectrometry

Diego Rodríguez Cabaleiro1, Dietmar Stöckl1, Jean M. Kaufman2, Tom Fiers2 and Linda M. Thienpont1,a

1 Laboratory for Analytical Chemistry, Faculty of Pharmaceutical Sciences, Ghent University, Gent, Belgium;2 Laboratory for Hormonology and Department of Endocrinology, Ghent University Hospital, Gent, Belgium;

aaddress correspondence to this author at: Laboratory for Analytical Chemistry, Faculty of Pharmaceutical Sciences, Ghent University, Harelbekestraat 72, B-9000 Gent, Belgium; fax 32-9-264-81-98, e-mail linda.thienpont{at}ugent.be


Abstract

Background: Serum C-peptide concentrations reflect pancreatic function in different clinical and diagnostic settings; however, the utility of C-peptide testing is limited by the lack of standardized commercial immunoassays. Standardization can best be done by split-sample comparison with a hierarchically higher reference measurement procedure with a set of native sera. For serum peptides, isotope-dilution liquid chromatography–mass spectrometry (ID-LC/MS) is recommended as a reference measurement procedure.

Methods: We evaluated the analytical performance characteristics of an ID-LC/tandem MS procedure for measurement of serum C-peptide after a 2-step solid-phase extraction. To investigate the feasibility of this procedure for use in standardization, we also performed a method comparison with 3 representative commercial assays.

Results: The ID-LC/tandem MS procedure showed maximum within-run, between-run, and total CVs on dedicated sera (C-peptide concentrations, 1.6 and 4.0 µg/L) of 2.1%, 2.5%, and 2.9%, respectively; an accuracy of 94.6%–104.1%; a minimum trueness of 98.1% (95% confidence interval, 96.2%–100.0%), and limits of quantification and detection of 0.15 and 0.03 µg/L, respectively. Deming linear regression analysis of the method-comparison data showed that the immunoassays correlated well with ID-MS and were specific, but lacked intercomparability and trueness. We propose that the deficiencies can be resolved by recalibration on the basis of the method comparison.

Conclusions: The ID-LC/tandem MS procedure is suitable for specific and accurate measurement of basal and stimulated serum concentrations of proinsulin C-peptide fragment 33–63 and is suitable for use in standardization of C-peptide immunoassays.




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
R. R. Little, C. L. Rohlfing, A. L. Tennill, R. W. Madsen, K. S. Polonsky, G. L. Myers, C. J. Greenbaum, J. P. Palmer, E. Rogatsky, and D. T. Stein
Standardization of C-Peptide Measurements
Clin. Chem., June 1, 2008; 54(6): 1023 - 1026.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. L. Hortin
A New Era in Protein Quantification in Clinical Laboratories: Application of Liquid Chromatography-Tandem Mass Spectrometry
Clin. Chem., April 1, 2007; 53(4): 543 - 544.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. Marcovina, R. R. Bowsher, W. G. Miller, M. Staten, G. Myers, S. P. Caudill, S. E. Campbell, M. W. Steffes, and for the Insulin Standardization Workgroup
Standardization of Insulin Immunoassays: Report of the American Diabetes Association Workgroup
Clin. Chem., April 1, 2007; 53(4): 711 - 716.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
H.-M. Wiedmeyer, K. S. Polonsky, G. L. Myers, R. R. Little, C. J. Greenbaum, D. E. Goldstein, and J. P. Palmer
International Comparison of C-Peptide Measurements
Clin. Chem., April 1, 2007; 53(4): 784 - 787.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Association for Clinical Chemistry.